IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i22p11912-d678269.html
   My bibliography  Save this article

Expectations for the Development of Health Technology Assessment in Brazil

Author

Listed:
  • Julia Simões Corrêa Galendi

    (Institute for Health Economics and Clinical Epidemiology (IGKE), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50935 Cologne, Germany)

  • Carlos Antonio Caramori

    (Department of Internal Medicine, Medical School, São Paulo State University (UNESP), 18618687 Botucatu, Brazil)

  • Clarissa Lemmen

    (Institute for Health Economics and Clinical Epidemiology (IGKE), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50935 Cologne, Germany)

  • Dirk Müller

    (Institute for Health Economics and Clinical Epidemiology (IGKE), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50935 Cologne, Germany)

  • Stephanie Stock

    (Institute for Health Economics and Clinical Epidemiology (IGKE), Faculty of Medicine and University Hospital Cologne, University of Cologne, 50935 Cologne, Germany)

Abstract

The implementation of health technology assessment (HTA) in emerging countries depends on the characteristics of the health care system and the needs of public health care. The objective of this survey was to investigate experts’ expectations for the development of HTA in Brazil and to derive measures to strengthen the impact of HTA in Brazil on health care decisions. Based on a scoping literature review, a questionnaire was developed proposing eight theses for seven domains of HTA: (i) capacity building, (ii) public involvement, (iii) role of cost-effectiveness analysis (CEA), (iv) institutional framework, (v) scope of HTA studies, (vi) methodology of HTA, and (vii) HTA as the basis for jurisdiction. Thirty experts responded in full to the survey and agreed to five of the eight theses proposed. Experts suggested several measures to promote HTA within the scope of each domain, thus addressing capacity building related to HTA, availability, and reliability of population data, and legal endowment of the HTA system. Finally, HTA processes in Brazil should also address public health issues (e.g., appraisal of interventions directed at chronic diseases).

Suggested Citation

  • Julia Simões Corrêa Galendi & Carlos Antonio Caramori & Clarissa Lemmen & Dirk Müller & Stephanie Stock, 2021. "Expectations for the Development of Health Technology Assessment in Brazil," IJERPH, MDPI, vol. 18(22), pages 1-12, November.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:22:p:11912-:d:678269
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/22/11912/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/22/11912/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Oortwijn, Wija & Mathijssen, Judith & Banta, David, 2010. "The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries," Health Policy, Elsevier, vol. 95(2-3), pages 174-184, May.
    2. Vargas-Peláez, Claudia Marcela & Rover, Marina Raijche Mattozo & Leite, Silvana Nair & Rossi Buenaventura, Francisco & Farias, Mareni Rocha, 2014. "Right to health, essential medicines, and lawsuits for access to medicines – A scoping study," Social Science & Medicine, Elsevier, vol. 121(C), pages 48-55.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Barbara Więckowska & Monika Raulinajtys-Grzybek & Katarzyna Byszek, 2022. "Using the Dynamic SWOT Analysis to Assess Options for Implementing the HB-HTA Model," IJERPH, MDPI, vol. 19(12), pages 1-17, June.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lianne Barnieh & Fiona Clement & Anthony Harris & Marja Blom & Cam Donaldson & Scott Klarenbach & Don Husereau & Diane Lorenzetti & Braden Manns, 2014. "A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development," PLOS ONE, Public Library of Science, vol. 9(3), pages 1-10, March.
    2. Vogler, Sabine & Zimmermann, Nina & de Joncheere, Kees, 2016. "Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015," Health Policy, Elsevier, vol. 120(12), pages 1363-1377.
    3. Zaheer-Ud-Din Babar & Shane Scahill, 2011. "The Authors’ Reply," PharmacoEconomics, Springer, vol. 29(1), pages 84-86, January.
    4. Vargas-Peláez, Claudia Marcela & Soares, Luciano & Rover, Marina Raijche Mattozo & Blatt, Carine Raquel & Mantel-Teeuwisse, Aukje & Rossi Buenaventura, Francisco Augusto & Restrepo, Luis Guillermo & L, 2017. "Towards a theoretical model on medicines as a health need," Social Science & Medicine, Elsevier, vol. 178(C), pages 167-174.
    5. Lopert, Ruth & Ruiz, Francis & Chalkidou, Kalipso, 2013. "Applying rapid ‘de-facto’ HTA in resource-limited settings: Experience from Romania," Health Policy, Elsevier, vol. 112(3), pages 202-208.
    6. Núria Homedes & Antonio Ugalde, 2016. "Health and Ethical Consequences of Outsourcing Pivotal Clinical Trials to Latin America: A Cross-Sectional, Descriptive Study," PLOS ONE, Public Library of Science, vol. 11(6), pages 1-17, June.
    7. Pragyan Monalisa Sahoo & Himanshu Sekhar Rout & Mihajlo Jakovljevic, 2023. "Dynamics of Health Financing among the BRICS: A Literature Review," Sustainability, MDPI, vol. 15(16), pages 1-21, August.
    8. Oriana Ciani & Britni Wilcher & Anoukh van Giessen & Rod S. Taylor, 2017. "Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 13-29, February.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:22:p:11912-:d:678269. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.